Screener
McKesson MCK Prescription Technology Solutions — Total other segment expense, net
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---|---|
| Other segment expense, net (2) | ||
| North American Pharmaceutical (3) | $85,870 | $82,135 |
| Oncology & Multispecialty | 13,897 | 10,446 |
| Prescription Technology Solutions (4) | 1,340 | 1,181 |
| Medical-Surgical Solutions (5) | 2,697 | 2,480 |
| Other | — | 292 |
| Total other segment expense, net | $103,804 | $96,534 |
| Segment operating profit |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's prescription technology solutions — total other segment expense, net?
- McKesson (MCK) reported prescription technology solutions — total other segment expense, net of $1.34B in Q2 2026.
- How has McKesson's prescription technology solutions — total other segment expense, net changed year-over-year?
- McKesson's prescription technology solutions — total other segment expense, net increased by 13.5% year-over-year, from $1.18B to $1.34B.
- What is the long-term trend for McKesson's prescription technology solutions — total other segment expense, net?
- Over 3 years (2023 to 2026), McKesson's prescription technology solutions — total other segment expense, net has grown at a 7.6% compound annual growth rate (CAGR), from $3.82B to $4.76B.
- What does prescription technology solutions — total other segment expense, net mean?
- This metric reflects the net total of miscellaneous expenses incurred by the Prescription Technology Solutions segment that are not classified as direct operating costs. It captures overhead, administrative, or other indirect costs associated with running the segment. Monitoring this helps assess the segment's operational efficiency.
Ask your AI about McKesson's prescription technology solutions — total other segment expense, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude